Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1960 Mar;15(1):160–164. doi: 10.1111/j.1476-5381.1960.tb01225.x

Metabolism and excretion of di(p-aminophenyl) sulphoxide in different animals species

A A Levi, G A Snow
PMCID: PMC1481985  PMID: 14416172

Abstract

Rabbits, rats and guinea-pigs were treated with di(p-aminophenyl) sulphoxide and their urines examined by an analytical method which permits the simultaneous determination of this compound and of dapsone [di(p-aminophenyl) sulphone] which is a possible product of metabolic oxidation. The method gives for each drug the total of free compound plus acid-labile conjugates. All three species excreted unchanged drug together with dapsone. With rats and guinea-pigs about 33% of the excretion is dapsone, but with rabbits only 6 to 12%. The rate of combined excretion is much greater in rabbits than in the other two species. These results are discussed in relation to the significance of di(p-aminophenyl) sulphoxide as a drug in the treatment of leprosy.

Full text

PDF
164

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRODIE B. B., SALZMAN N. P. Physiological disposition and fate of chlorpromazine and a method for its estimation in biological material. J Pharmacol Exp Ther. 1956 Sep;118(1):46–54. [PubMed] [Google Scholar]
  2. BURNS J. J., YU T. F., RITTERBAND A., PEREL J. M., GUTMAN A. B., BRODIE B. B. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther. 1957 Mar;119(3):418–426. [PubMed] [Google Scholar]
  3. BUSHBY S. R., WOIWOD A. J. The identification of the major diazotizable metabolite of 4:4'-diaminodiphenyl sulphone in rabbit urine. Biochem J. 1956 Jul;63(3):406–408. doi: 10.1042/bj0630406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BUU-HOI N. P., NGUYEN-BA-KHUYEN, NGUYEN-DAT-XUONG Six mois de chimiothérapie antilépreuse au Sud-Vietnam avec le 4,4'-diaminodiphénylsulfoxyde et le 4,4'-diéthoxythiocarbanilide. Bull Acad Natl Med. 1955 May 3;139(15-16):275–280. [PubMed] [Google Scholar]
  5. DAVEY T. F., KISSAUN A. M., MONETA G. The treatment of leprosy with diaminodiphenyl sulphoxide: a progress report. Lepr Rev. 1957 Apr;28(2):51–59. doi: 10.5935/0305-7518.19570006. [DOI] [PubMed] [Google Scholar]
  6. FRANCIS J., SPINKS A. Antibacterial action and metabolism of five sulphones. Br J Pharmacol Chemother. 1950 Dec;5(4):565–583. doi: 10.1111/j.1476-5381.1950.tb00608.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. LAVIRON P., LAURET L., KERBASTARD P., JARDIN C. Le 4, 4'-diaminodiphénylsulfoxyde dans le traitement de la lèpre. Bull Acad Natl Med. 1957 Mar 5;141(9-10):195–204. [PubMed] [Google Scholar]
  8. SNOW G. A. The metabolism of compounds related to ethanethiol. Biochem J. 1957 Jan;65(1):77–82. doi: 10.1042/bj0650077. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES